Zhongnan Medical Journal Press

Home Results

A total of 26 result was found. Results that relate to Rapid health technology assessment

Efgartigimod alfa in the treatment of generalized myasthenia gravis: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1156-1163.
8096 times 1343 times

HUANG Gerile LI Yujie ZHANG Wenjing GUO Hao

Efgartigimod alfa Myasthenia gravis Rapid health technology assessment Efficaey Safety Economy
Details
Tofacitinib for the treatment of ulcerative colitis: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(12):1414-1424.
13505 times 1191 times

LI Huiling DUAN Yinyin LI Qianqian WU Xiaoli

Tofacitinib Ulcerative colitis Rapid health technology assessment
Details
Vonoprazan for ulcers associated with endoscopic submucosal dissection: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(3):306-313.
6582 times 1059 times

WANG Wei KE Yijun CHENG Chang FANG Chongwen PAN Lisheng JIN Yong ZHANG Yanping

Vonoprazan Endoscopic submucosal dissection Ulcer Rapid health technology assessment
Details
Venetoclax in the treatment of non-M3 acute myeloid leukemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(3):314-323.
6758 times 979 times

ZHANG Yazhuo LI Huiling Duan Yinyin SHI Yuye

Venetoclax Non-M3 acute myeloid leukemia Rapid health technology assessment
Details
Dorzagliatin in the treatment of type 2 diabetes：a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):448-455.
10311 times 2299 times

LI Yujie ZHANG Wenjing YANG Hongxin GUO Hao

Dorzagliatin Type 2 diabetes mellitus Rapid health technology assessment Efficacy Safety Economy
Details
Sugemalimab as first-line treatment for non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):806-814.
4656 times 662 times

HOU Yibing KANG Shuo GONG Yuan WANG Xiaohui NIE Ying LIU Huanlong

Sugemalimab Non-small cell lung cancer Effectiveness Safety Economics Rapid health technology assessment
Details
Tirzepatide in the treatment of type 2 diabetes mellitus: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1057-1065.
5771 times 455 times

ZHANG Yunxuan ZHOU Haifeng GAO Ningzhou WU Jianbo QIAN Cheng ZHANG Min GUO Han SONG Zhongjuan LIU Xiaoyan

Tirzepatide Type 2 diabetes mellitus Rapid health technology assessment Efficacy Safety Cost-effectiveness
Details
Inclisiran in the treatment of dyslipidemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(10):1198-1205.
2039 times 264 times

CHEN Lingbin PAN Weiping CHEN Zhou XU Wentan

Inclisiran Dyslipidemia Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details
Rapid health technology assessment of linezolid for the treatment of complicated lower respiratory tract infections

Published on Frontiers in Pharmaceutical Sciences 2025,29(10):1731-1737.
1110 times 165 times

LANG Yan PAN Jiahui WANG Ling

Linezolid Lower respiratory tract infection Rapid health technology assessment
Details
Toripalimab for the treatment of advanced esophageal cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1302-1310.
538 times 115 times

YANG Shou NIE Ying GONG Yuan KANG Shuo HOU Yibing WANG Xiaohui PAN Zhenhua

Toripalimab Advanced esophageal cancer Rapid health technology assessment Effectiveness Safety Economy
Details
Rapid health technology assessment of avatrombopag for the treatment of primary immune thrombocytopenia in adults

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1311-1319.
521 times 110 times

LI Zhou LING Ya ZHANG Jie ZHU Ling

Avatrombopag Primary immune thrombocytopenia Efficacy Safety Economy Rapid health technology assessment
Details